A common variant of CDKN2A (p16) predisposes to breast cancer

被引:61
|
作者
Debniak, T
Górski, B
Huzarski, T
Byrski, T
Cybulski, C
Mackiewicz, A
Gozdecka-Grodecka, S
Gronwald, J
Kowalska, E
Haus, O
Grzybowska, E
Stawicka, M
Swiec, M
Urbanski, K
Niepsuj, S
Wasko, B
Gózdz, S
Wandzel, P
Szczylik, C
Surdyka, D
Rozmiarek, A
Zambrano, O
Posmyk, M
Narod, SA
Lubinski, J
机构
[1] Univ Toronto, Ctr Res Womens Hlth, Toronto, ON M5G 1N8, Canada
[2] Pomeranian Med Univ, Int Hereditary Canc Ctr, Dept Genet & Pathol, Szczecin, Poland
[3] Dept Canc Immunol, Poznan, Poland
[4] Dept Clin Genet, Bydgoszcz, Poland
[5] Maria Sklodowska Curie Inst, Dept Tumour Biol, Gliwice, Poland
[6] Prophylact & Epidemiol Ctr, Poznan, Poland
[7] Reg Oncol Hosp, Opole, Poland
[8] Reg Oncol Ctr, Krakow, Poland
[9] Reg Oncol Hosp, Olsztyn, Poland
[10] Reg Hosp, Rzeszow, Poland
[11] Holycross Oncol Ctr, Kielce, Poland
[12] Reg Hosp, Bielsko Biala, Poland
[13] Mil Hosp, Warsaw, Poland
[14] Reg Hosp, Lublin, Poland
[15] Reg Oncol Hosp, Zielona Gora, Poland
[16] Reg Hosp, Lodz, Poland
[17] Reg Oncol Hosp, Bialystok, Poland
关键词
D O I
10.1136/jmg.2005.031476
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: A common missense variant of the CDKN2A gene (A148T) predisposes to malignant melanoma in Poland. An association between malignant melanoma and breast cancer has been reported in several families with CDKN2A mutations, Objective: To determine whether this variant also predisposes to breast cancer. Methods: Genotyping was undertaken in 4209 cases of breast cancer, unselected for family history, from 18 hospitals throughout Poland and in 3000 controls. Results: The odds ratio ( OR) associated with the CDKN2A allele for women diagnosed with breast cancer before the age of 50 was 1.5 ( p = 0.002) and after age 50 it was 1.3 ( p = 0.2). The effect was particularly strong for patients diagnosed at or before the age of 30 ( OR = 3.8; p = 0.0002). Conclusions: CDKN2A appears to be a low penetrance breast cancer susceptibility gene in Poland. The association should be confirmed in other populations.
引用
收藏
页码:763 / 765
页数:3
相关论文
共 50 条
  • [41] Genetic alterations in gastrinomas: An analysis of p16/CDKN2A tumor suppressor gene
    Serrano, J
    Goebel, SU
    Gibril, F
    Jensen, RT
    GASTROENTEROLOGY, 1999, 116 (04) : A1162 - A1162
  • [42] Patterns of photoprotection following CDKN2A/p16 genetic test reporting and counseling
    Aspinwall, Lisa G.
    Leaf, Saniantha L.
    Kohlmann, Wendy
    Dola, Erin R.
    Leachman, Sancy A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2009, 60 (05) : 745 - 757
  • [43] CDKN2A/p16, RB and CDK4 alterations in osteosarcoma.
    Nielsen, GP
    Burns, K
    Rosenberg, AE
    Louis, DN
    LABORATORY INVESTIGATION, 1998, 78 (01) : 13A - 13A
  • [44] Study of CDKN2A and p16 in malignant pleural mesothelioma in relation to asbestos exposure
    Wolff, H.
    Kettunen, E.
    Savukoski, S.
    Vanhala, E.
    Salmenkivi, K.
    Bohling, T.
    Kuosma, E.
    Anttila, S.
    VIRCHOWS ARCHIV, 2017, 471 : S107 - S107
  • [45] CDKN2A (P16) AND HRAS ARE FREQUENTLY MUTATED IN VULVAR SQUAMOUS CELL CARCINOMA
    Trietsch, M. D.
    Spaans, V. M.
    ter Haar, N. T.
    Osse, E. M.
    Peters, A. A. W.
    Gaarenstroom, K. N.
    Fleuren, G. J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [46] Absence of p16 gene (CDKN2A) deletions in HNSCC occurring in young adults
    O'Regan, EM
    Sheils, OM
    Murphy, NC
    Ring, M
    Toner, ME
    Finn, SP
    Smyth, PC
    Cahill, S
    O'Leary, JJ
    MODERN PATHOLOGY, 2005, 18 : 216A - 216A
  • [47] p16 Immunohistochemistry as a Screening Tool for Homozygous CDKN2A Deletions in CNS Tumors
    Zschernack, Valentina
    Andreiuolo, Felipe
    Doerner, Evelyn
    Wiedey, Anna
    Juenger, Stephanie T.
    Friker, Lea L.
    Maruccia, Riccardo
    Pietsch, Torsten
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2024, 48 (01) : 46 - 53
  • [48] Melanoma genetics: An update with focus on the CDKN2A(p16)/ARF tumor suppressors
    Piepkorn, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (05) : 705 - 722
  • [49] Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma
    Takita, J
    Hayashi, Y
    Kohno, T
    Yamaguchi, N
    Hanada, R
    Yamamoto, K
    Yokota, J
    CANCER RESEARCH, 1997, 57 (05) : 907 - 912
  • [50] Two p16 (CDKN2A) germline mutations in 30 Israeli melanoma families
    Yakobson, E
    Shemesh, P
    Azizi, E
    Winkler, E
    Lassam, N
    Hogg, D
    Brookes, S
    Peters, G
    Lotem, M
    Zlotogorski, A
    Landau, M
    Safro, M
    Shafir, R
    Friedman, E
    Peretz, H
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2000, 8 (08) : 590 - 596